Byakika-Kibwika, PaulineLamorde, MohammedMayito, JonathanNabukeera, LillianNamakula, RhodaMayanja-Kizza, HarrietKatabira, EllyNtale, MuhammadPakker, NadineRyan, MairinHanpithakpong, WaruneeTarning, JoelLindegardh, NiklasVries, Peter J. deKhoo, SayeBack, David2022-01-142022-01-142012Byakika-Kibwika, P., Lamorde, M., Mayito, J., Nabukeera, L., Namakula, R., Mayanja-Kizza, H., ... & Merry, C. (2012). Significant pharmacokinetic interactions between artemether/lumefantrine and efavirenz or nevirapine in HIV-infected Ugandan adults. Journal of Antimicrobial Chemotherapy, 67(9), 2213-2221. doi:10.1093/jac/dks20710.1093/jac/dks207https://nru.uncst.go.ug/xmlui/handle/123456789/1277Co-administration of artemether/lumefantrine with antiretroviral therapy has potential for pharmacokinetic drug interactions. We investigated drug–drug interactions between artemether/lumefantrine and efavirenz or nevirapine. Methods: We performed a cross-over study in which HIV-infected adults received standard six-dose artemether/ lumefantrine 80/480 mg before and at efavirenz or nevirapine steady state. Artemether, dihydroartemisinin, lumefantrine, efavirenz and nevirapine plasma concentrations were measured and compared.enAntimalarialAntiretroviralMalariaDrugsArticle